Stuart Watson

Has grant

Newcastle University
Country flagUnited Kingdom

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Aripiprazole/ sertraline combination: Clinical and cost-effectiveness in comparison with quetiapine for the treatment of bipolar depression. An open label randomised controlled trial. (ASCEnD)

Open Date: 2022-09-01

Close Date: 2026-08-01

Grant: Close

PAX-D: Randomised placebo-controlled trial evaluating the efficacy and mechanism of pramipexole as add-on treatment for people with treatment resistant depression

Open Date: 2019-04-01

Close Date: 2023-04-01

Grant: Close

CANnabidiol as a Treatment fOr Psychosis clinical high-risk state- a Randomised Clinical Trial (CANTOP-RCT)

Open Date: 2018-09-01

Close Date: 2023-06-01

Grant: Close

Randomised placebo controlled trial of Pramipexole addition to mood stabilisers for treatment resistant bipolar depression (the PAX-BD study)

Open Date: 2018-04-01

Close Date: 2022-04-01

Grant: Close

Language and Mental Health

Open Date: 2014-03-30

Close Date: 2017-09-29

Articles (10)

Background Recent evidence suggests that the first consultation with a general practitioner (GP) for symptoms of depression may be more than just a vehicle for assessment and management planning (as current guidelines imply). Objectives To identify what patients find helpful, or otherwise, in their first consultation for low mood with a GP. Methods A cross-sectional questionnaire and interview study of patients with low mood who had recently consulted their GP, in the North of England. Patients were asked to complete a questionnaire regarding the consultation, and a Patient Health Questionnaire-9 (PHQ-9), within 2 weeks. They were also invited to take part in a face–face interview with a researcher. Both sources of data were subjected to qualitative thematic analysis. Results Thirty-seven questionnaires were returned; 5 interviews took place. The majority of participants felt better after consulting a GP for the first time for low mood. The factors most commonly cited as helpful were “being listened to” and “understanding or empathy from the GP.” Others included “admitting the problem,” “being reassured of normality,” and “being provided with optimism or hope for change.” The most commonly reported difficulty was the patients’ struggle to express themselves. Patients often felt that GP follow-up was inadequate. Conclusions These results suggest that the therapeutic benefit of the GP consultation is under-recognized in current guidelines. The results of our study will provide crucial information as to how such consultations can be tailored to improve patient satisfaction.

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (6)

Andrew M. Blamire

-

UNITED KINGDOM
View details

James Griffiths

Head of Clinical Trial Operations

NHS Blood and Transplant

UNITED KINGDOM
View details

Jonathan Evans

University of Bristol

UNITED KINGDOM
View details

Sheena Au-Yeung

University of Sheffield

UNITED KINGDOM
View details

mary jane Attenburrow

Head of Clinical Research

-

UNITED KINGDOM
View details

Hamish McAllister-Williams

Professor of Affective Disorders

Newcastle University

UNITED KINGDOM
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.